Courses & Units
Clinical Pharmacokinetics 3 CSA311
Introduction
This unit studies factors influencing the bioavailability and disposition of medications, and the application of this information to optimise the quality use of medicines in clinical practice. Particular emphasis is placed on the clinical role of the pharmacist and problem-solving in improving the use of medications through the practical application of pharmacokinetics. This information is also applicable to students not completing a pharmacy degree (e.g. to science-based students who wish to pursue a career in pharmaceutical industry or research). Topics include: Clinical Pharmacokinetics: Processes of absorption, distribution, metabolism and excretion of medications; kinetics of intravenous and extravascular dosing, and relevant calculations. Biopharmaceutics: Concepts of bioavailability and bioequivalence (including generic substitution and biosimilars); factors influencing bioavailability (physiological and pharmaceutical); drug delivery systems and recent developments.
Summary
Unit name | Clinical Pharmacokinetics 3 |
---|---|
Unit code | CSA311 |
Credit points | 12.5 |
College/School | College of Health and Medicine School of Pharmacy and Pharmacology |
Discipline | Pharmacy |
Coordinator | Mr Cameron Randall|Doctor Daniel Hoyle |
Available as an elective? | No |
Delivered By | University of Tasmania |
Level | Advanced |
Availability
Location | Study period | Attendance options | Available to | ||
---|---|---|---|---|---|
Hobart | Summer school | On-Campus | International | Domestic | |
Hobart | Health Study Period 2 | On-Campus | International | Domestic | |
Hobart | Health Study Period 3 | On-Campus | International | Domestic | |
Launceston | Health Study Period 3 | On-Campus | International | Domestic | |
Cradle Coast | Health Study Period 3 | On-Campus | International | Domestic |
Key
- On-campus
- Off-Campus
- International students
- Domestic students
Note
Please check that your computer meets the minimum System Requirements if you are attending via Distance/Off-Campus.
Units are offered in attending mode unless otherwise indicated (that is attendance is required at the campus identified). A unit identified as offered by distance, that is there is no requirement for attendance, is identified with a nominal enrolment campus. A unit offered to both attending students and by distance from the same campus is identified as having both modes of study.
Key Dates
Study Period | Start date | Census date | WW date | End date |
---|---|---|---|---|
Health Study Period 2 | 8/7/2024 | 26/7/2024 | 23/8/2024 | 6/10/2024 |
Health Study Period 3 | 4/11/2024 | 22/11/2024 | 20/12/2024 | 2/2/2025 |
Summer school | 2/1/2024 | 15/1/2024 | 30/1/2024 | 25/2/2024 |
* The Final WW Date is the final date from which you can withdraw from the unit without academic penalty, however you will still incur a financial liability (refer to How do I withdraw from a unit? for more information).
Unit census dates currently displaying for 2024 are indicative and subject to change. Finalised census dates for 2024 will be available from the 1st October 2023. Note census date cutoff is 11.59pm AEST (AEDT during October to March).
Learning Outcomes
- Apply pharmacokinetic principles and calculations to solve clinical problems that may contribute to improved quality use of medicines.
- Describe various methods of drug delivery, select appropriate options based on individual patient circumstance, and outline relevant regulatory procedures governing generic and biosimilar medicines.
- Provide accurate and appropriate health and medicines advice to a range of consumers (including other health professionals).
- Search and evaluate drug information and pharmacy related literature.
Fee Information
Field of Education | Commencing Student Contribution 1,3 | Grandfathered Student Contribution 1,3 | Approved Pathway Course Student Contribution 2,3 | Domestic Full Fee 4 |
---|---|---|---|---|
019907 | $1,118.00 | $1,118.00 | not applicable | $2,596.00 |
1 Please refer to more information on student contribution amounts.
2 Please refer to more information on eligibility and Approved Pathway courses.
3 Please refer to more information on eligibility for HECS-HELP.
4 Please refer to more information on eligibility for FEE-HELP.
If you have any questions in relation to the fees, please contact UConnect or more information is available on StudyAssist.
Please note: international students should refer to What is an indicative Fee? to get an indicative course cost.
Requisites
Prerequisites
CSA231 AND CSA230 AND All Year 1 BPharm UnitsTeaching
Teaching Pattern | Online learning resources (equivalent to 2 hours of activity per week) and1 x 2hr workshop weekly. |
---|---|
Assessment | Regular test (15%)|Paired written assignment (20%)|Mid Semester Test (25%)|Examination (40%) |
Timetable | View the lecture timetable | View the full unit timetable |
Textbooks
Required |
No required reading materials. |
---|---|
Recommended | Birkett DJ. Pharmacokinetics Made Easy, McGraw Hill: 2010. Shargel L, Wu-Pong S, Yu ABC: Applied Biopharmaceutics and Pharmacokinetics, 7th Edition, McGraw Hill: 2015. (accessible for free via Access Pharmacy online) | Links | Booktopia textbook finder |
The University reserves the right to amend or remove courses and unit availabilities, as appropriate.